Postpartum Depression Epidemiology Forecast

"DelveInsight’s ‘Postpartum Depression (PPD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Postpartum Depression (PPD) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.  


Geographies Covered

• The United States

• EU5 (Germany, France, Italy, Spain, and the United Kingdom)

• Japan


Study Period: 2017–2030


Postpartum Depression (PPD) Understanding

Postpartum depression (PPD) is the most common non-psychotic, complication of childbearing affecting approximately 10–15% of women and as such, represents a considerable public health problem affecting women and their families. The postnatal period is well established as an increased time of risk for the development of serious mood disorders. There are three common forms of postpartum affective illness: the blues (baby blues, maternity blues), postpartum (or postnatal) depression, and puerperal (postpartum or postnatal) psychosis each of which differs in its prevalence, clinical presentation, and management.


Postpartum depression usually begins within 1–12 months after delivery. In some women, post-partum blues simply continue and become more severe. In others, a period of wellbeing after delivery is followed by a gradual onset of depression. The patterns of symptoms in women with postpartum depression are similar to those in women who have depression unrelated to childbirth. Several factors can lead to postpartum depression. Women with a history of depression and other mental health conditions face a higher risk of PPD. 


Postpartum Depression (PPD) Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Diagnosed Prevalent Population of Maternal Postpartum Depression and Type-specific Diagnosed Prevalence of Postpartum Depression scenario of Postpartum Depression (PPD) in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030.


Postpartum Depression (PPD) Detailed Epidemiology Segmentation

• In the 7MM, the total diagnosed prevalent cases of PPD in 2017 were 1,134,800 out of which the highest diagnosed prevalent cases of this disease were seen in the United States, which were 609,900, which is expected to increase during forecast period (2020–2030). 

• As per the estimates, In Japan the diagnosed prevalence of PPD was found to be the second highest after the US with 116,280 in 2017.


Scope of the Report

• The report covers the descriptive overview of Postpartum Depression (PPD), explaining its causes, signs and symptoms, pathophysiology.

• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan.

• The report assesses the disease risk and burden and highlights the unmet needs of Postpartum Depression (PPD).

• The report provides the segmentation of the disease epidemiology for 7MM by Total Prevalent Cases of Postpartum Depression (PPD), Total Diagnosed and Treated Cases of Postpartum Depression (PPD).


Report Highlights

• Eleven Year Forecast of Postpartum Depression (PPD)

• Diagnosed Prevalent Population of both Maternal as well as Paternal PPD has been covered. The occurrence of maternal PPD is more profound as compared to paternal PPD, however, a small proportation of males also suffer from depression post child birth

• Report also provides type-specific diagnosed prevalence of PPD, which comprises of Postpartum blues, Obsessive Compulsive Disorder post-pregnancy, Postpartum Psychosis, Posttraumatic stress disorder (PTSD) and Postpartum Panic Disorder

• 7MM Coverage 


Key Questions Answered

• What is the disease risk, burden and unmet needs of Postpartum Depression (PPD)?

• What is the historical Postpartum Depression (PPD) patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?

• What would be the forecasted patient pool of Postpartum Depression (PPD) at the 7MM level?

• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Postpartum Depression (PPD)?

• Out of the above-mentioned countries, which country would have the highest prevalent population of Postpartum Depression (PPD) during the forecast period (2020–2030)?

• At what CAGR the population is expected to grow across the 7MM during the forecast period (2020–2030)?


Reasons to buy

The Postpartum Depression (PPD) report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the 7MM Postpartum Depression (PPD) market.

• Quantify patient share distribution in the 7MM for Postpartum Depression (PPD). 

• The Postpartum Depression (PPD) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.

• The Postpartum Depression (PPD) epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the eleven-year forecast period using reputable sources.


Key Assessments

• Patient Segmentation

• Disease Risk and Burden

• Risk of disease by the segmentation 

• Factors driving growth in a specific patient population

1 Key Insights

2 Postpartum depression (PPD) Overview at a Glance

3 Disease Background and Overview: Postpartum depression (PPD)

3.1 Introduction

3.2 Clinical Presentation

3.3 Risk Factors

3.4 Pathogenesis

3.5 Diagnosis and Screening

3.5.1 Diagnostic Criteria

4 Epidemiology and Patient Population

4.1 Key Findings

4.1 7MM Total Diagnosed Prevalent Population of Postpartum Depression (PPD)

5 Country-Wise Epidemiology of Postpartum Depression (PPD)

5.1 United States

5.1.1 Assumptions and Rationale

5.1.2 Total Diagnosed Prevalent Population of Maternal Postpartum Depression in the United States

5.1.3 Type-specific Diagnosed Prevalence of Postpartum Depression in the United States

5.2 EU5 Countries

5.3 Germany

5.3.1 Assumptions and Rationale

5.3.1 Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Germany

5.3.2 Type-specific Diagnosed Prevalence of Postpartum Depression in Germany

5.4 France

5.4.1 Assumptions and Rationale

5.4.1 Total Diagnosed Prevalent Population of Maternal Postpartum Depression in France

5.4.2 Type-specific Diagnosed Prevalence of Postpartum Depression in France

5.5 Italy

5.5.1 Assumptions and Rationale

5.5.1 Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Italy

5.5.2 Type-specific Diagnosed Prevalence of Postpartum Depression in Italy

5.6 Spain

5.6.1 Assumptions and Rationale

5.6.1 Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Spain

5.6.2 Type-specific Diagnosed Prevalence of Postpartum Depression in Spain

5.7 United Kingdom

5.7.1 Assumptions and Rationale

5.7.1 Total Diagnosed Prevalent Population of Maternal Postpartum Depression in the United Kingdom

5.7.2 Type-specific Diagnosed Prevalence of Postpartum Depression in the United Kingdom

5.8 Japan

5.8.1 Assumptions and Rationale

5.8.1 Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Japan

5.8.2 Type-specific Diagnosed Prevalence of Postpartum Depression in Japan

6 Recognized Establishments

7 Appendix

8 Bibliography

9 Report Methodology

10 DelveInsight Capabilities

11 Disclaimer

12 About DelveInsight

Table 1: Symptoms of Major Depressive Disorder

Table 2: Key Recommendations For Practice

Table 3: Depression in DSM

Table 4: DSM-V Diagnostic Criteria for Major Depressive Episode

Table 5: Total Diagnosed Prevalent Population of PPD in the 7MM (2017–2030)

Table 6: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in the US (2017–2030)

Table 7: Type-specific Diagnosed Prevalence of Postpartum Depression in the US (2017–2030)

Table 8: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Germany (2017–2030)

Table 9: Type-specific Diagnosed Prevalence of Postpartum Depression in Germany (2017–2030)

Table 10: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in France (2017–2030)

Table 11: Type-specific Diagnosed Prevalence of Postpartum Depression in France (2017–2030)

Table 12: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Italy (2017–2030)

Table 13: Type-specific Diagnosed Prevalence of Postpartum Depression in Italy (2017–2030)

Table 14: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Spain (2017–2030)

Table 15: Type-specific Diagnosed Prevalence of Postpartum Depression in Spain (2017–2030)

Table 16: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in the UK (2017–2030)

Table 17: Type-specific Diagnosed Prevalence of Postpartum Depression in the UK (2017–2030)

Table 18: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Japan (2017–2030)

Table 19: Type-specific Diagnosed Prevalence of Postpartum Depression in Japan (2017–2030)

Figure 1: Total Diagnosed Prevalent Population of Postpartum Depression in the 7MM (2017–2030)

Figure 2: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in the US (2017–2030)

Figure 3: Type-specific Diagnosed Prevalence of Postpartum Depression in the US (2017–2030)

Figure 4: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Germany (2017–2030)

Figure 5: Type-specific Diagnosed Prevalence of Postpartum Depression in Germany (2017–2030)

Figure 6: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in France (2017–2030)

Figure 7: Type-specific Diagnosed Prevalence of Postpartum Depression in France (2017–2030)

Figure 8: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Italy (2017–2030)

Figure 9: Type-specific Diagnosed Prevalence of Postpartum Depression in Italy (2017–2030)

Figure 10: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Spain (2017–2030)

Figure 11: Type-specific Diagnosed Prevalence of Postpartum Depression in Spain (2017–2030)

Figure 12: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in the UK (2017–2030)

Figure 13: Type-specific Diagnosed Prevalence of Postpartum Depression in the UK (2017–2030)

Figure 14: Total Diagnosed Prevalent Population of Maternal Postpartum Depression in Japan (2017–2030)

Figure 15: Type-specific Diagnosed Prevalence of Postpartum Depression in Japan (2017–2030)

  • Tags:
  • Postpartum Depression Epidemiology
  • Postpartum Depression
  • Postpartum Depression Pipeline
  • Postpartum Depression Companies
  • Postpartum Depression prevalent po...
  • Postpartum Depression incident pop...
  • Postpartum Depression patients dia...
  • Postpartum Depression treatment al...

Forward to Friend

Need A Quote